Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Robotic upper-limb rehab vs standard therapy for adults with tetraplegia

Official title: Efficacy of Robotic Upper Limb Rehabilitation Training in Patients With Tetraplegia (TRRAT): A Pilot, Multicenter, Randomized Controlled Trial

Run by IRCCS Sacro Cuore Don Calabria di Negrar · NCT07860827 · Data updated 2026-11-12

This study tests whether a robotic arm rehabilitation device (PABLO®) plus standard therapy helps people with tetraplegia recover more upper-limb strength than standard rehab alone.

More Tetraplegia/Tetraparesis trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment24 (estimated)
SponsorIRCCS Sacro Cuore Don Calabria di Negrar
Academic / other
Locations1 site (Negrar, Veneto)
StatusRecruiting
StartedApril 1, 2024
Main results expectedOctober 1, 2027
Study endsOctober 31, 2027
Registry record updatedOctober 6, 2026
Trial IDNCT07860827 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 with tetraplegia/tetraparesis from spinal cord injury, able to move against gravity in at least one scapulohumeral or elbow muscle group, and within 120 days of injury.

Probably not a fit

Participants who do not show sufficient motor strength gains or who cannot tolerate the robotic device may experience no additional benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In adults with tetraplegia from spinal cord injury, the trial compares two 3-week training approaches after an initial standard upper-limb rehab period. One group uses a robotic rehabilitation device (PABLO®) for the upper limb, while the other continues with standard physiotherapy. Assessments include the ASIA Impairment Scale for neurological status and the MRC scale for proximal upper-limb strength, with evaluations at baseline, after the standard rehab period, after the training phase, and at the end of the study. Participants are randomized after a 2–4 week hospitalization and must meet specific motor and stability criteria.

Why it matters

Potential benefit: If successful, the robotic approach could enhance proximal upper-limb strength and improve functional recovery for people with tetraplegia.

How similar studies have gone: Similar robotic rehabilitation approaches have shown promise in related spinal cord injury rehab settings, but this exact protocol is novel in its randomized comparison.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. PRIMARY

   * The investigator obtains the patient's informed consent to participate in the clinical trial and to the processing of personal data.
   * Tetraplegic/tetraparetic patients with spinal cord injury of various etiologies (traumatic, ischemic, infectious, etc.) as defined by the ASIA Impairment Scale, who are capable of movements at least against gravity-even with a partial range of motion (MRC ≥2/5)-in the muscles of the scapulohumeral region and the elbow on at least one side of the body.
   * Age ≥ 18 years and ≤ 80 years.
   * Time interval between the acute event and study enrollment not exceeding 120 days.
2. SECONDARY

   * Ability to maintain a seated position in a non-reclined wheelchair (trunk-pelvis angle of 90°) for one hour.
   * Improvement in strength of ≥ 1 point (out of 5) on the MRC scale in less than half of the upper limb regions assessed at Visit V1.

Exclusion Criteria:

* ASIA with a neurological level of C2 or higher.
* Previous cerebrovascular events, neurodegenerative disorders, or spinal cord injuries that have resulted in motor and/or cognitive impairment.
* History of major psychiatric disorders.
* Concurrent traumatic brain injury during the acute phase.
* Previous orthopedic conditions of the shoulder resulting in severe functional impairment.
* Active rheumatological conditions.
* Severe uncorrected visual impairment (such that it prevents the patient from viewing the computer-based exercises proposed by the robot).

Where it's running

  • IRCCS Sacro Cuore Don Calabria Hospital
    Negrar, Veneto, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.